Autologous patient-specific tumor antigen response
Conventional medicine
⚠This is not folk medicine. This page describes a NON-traditional method (complementary/alternative or conventional medicine), outside FolkKB's folk/herbal focus. It is informational only — not medical advice, diagnosis or treatment. Evidence and safety vary widely; consult a qualified professional.
Autologous patient-specific tumor antigen response (apSTAR) technology is a new cancer treatment procedure being developed by IMULAN BioTherapeutics, LLC and Veterinary Cancer Therapeutics, LLC for comparative oncology.